719 Jadwin Avenue
Richland, WA 99352
United States
509-736-4000
https://www.radiogel.com
版塊: Healthcare
行業: Medical Devices
全職員工: 1
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. Michael K. Korenko Ph.D. | CEO, President & Director | 266.39k | 無 | 1946 |
Dr. Carlton M. Cadwell D.D.S. | Independent Chairman & Secretary | 無 | 無 | 1945 |
Mr. Michael H. Pollack CPA | Chief Financial Officer | 無 | 無 | 1966 |
Dr. David J. Swanberg M.S., P.E. | Chief Operating Officer | 無 | 無 | 1957 |
Dr. Fu-Min Su | Chief Radio Chemist & Radiation Safety Officer | 98.65k | 無 | 無 |
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
截至 無 止,Vivos Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。